ID
42608
Description
Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00864175
Link
https://clinicaltrials.gov/show/NCT00864175
Keywords
Versions (2)
- 8/9/17 8/9/17 -
- 9/17/21 9/17/21 -
Uploaded on
September 17, 2021
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Metastatic Breast Cancer NCT00864175
Eligibility Metastatic Breast Cancer NCT00864175
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Antineoplastic Agents
Data type
boolean
Alias
- UMLS CUI [1]
- C0003392
Description
Antineoplastic Agents | Breast Carcinoma Excluded
Data type
boolean
Alias
- UMLS CUI [1]
- C0003392
- UMLS CUI [2,1]
- C0678222
- UMLS CUI [2,2]
- C2828389
Description
Deep Vein Thrombosis
Data type
boolean
Alias
- UMLS CUI [1]
- C0149871
Description
Medical contraindication Warfarin Low dose
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0043031
- UMLS CUI [1,3]
- C0445550
Description
Cardiomyopathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0878544
Description
INCB007839 | trastuzumab | lapatinib
Data type
boolean
Alias
- UMLS CUI [1]
- C4305800
- UMLS CUI [2]
- C0728747
- UMLS CUI [3]
- C1506770
Similar models
Eligibility Metastatic Breast Cancer NCT00864175
- StudyEvent: Eligibility
C2348909 (UMLS CUI [1,2])
C0678222 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0043031 (UMLS CUI [1,2])
C0445550 (UMLS CUI [1,3])
C0728747 (UMLS CUI [2])
C1506770 (UMLS CUI [3])